Magnesium in subarachnoid haemorrhage: Proven beneficial?

Magnesium Research

Volumn 22, Issue 3, 2009, Pages 121-126

  van den Bergh, Walter M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Controlled clinical trial; Magnesium; Meta analysis; Subarachnoid haemorrhage

Indexed keywords

MAGNESIUM; NEUROPROTECTIVE AGENT;

ANIMAL; ARTICLE; HUMAN; META ANALYSIS; PHASE 3 CLINICAL TRIAL; SUBARACHNOID HEMORRHAGE;

ANIMALS; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; MAGNESIUM; META-ANALYSIS AS TOPIC; NEUROPROTECTIVE AGENTS; SUBARACHNOID HEMORRHAGE;

EID: 70349529614     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2009.0171     Document Type: Article

References (42)

1. van GijnJ, KerrRS, RinkelGJ. Subarachnoid haemorrhage. Lancet 2007; 369: 306-18.
2. LinnFH, RinkelGJ, AlgraA, van GijnJ. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke 1996; 27: 625-9.
3. FeiginVL, RinkelGJ, LawesCM, AlgraA, BennettDA, van GijnJ, etal. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005; 36: 2773-80.
4. BrilstraEH, RinkelGJ, AlgraA, van GijnJ. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology 2000; 55: 1656-60.
5. MolyneuxA, KerrR, StrattonI, SandercockP, ClarkeM, ShrimptonJ, etal. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002; 360: 1267-74.
6. DorschNW. Cerebral arterial spasm - a clinical review. Br J Neurosurg 1995; 9: 403-12.
7. RoosYB, de HaanRJ, BeenenLF, GroenRJ, AlbrechtKW, VermeulenM. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry 2000; 68: 337-41.
8. RabinsteinAA, FriedmanJA, WeigandSD, McClellandRL, FulghamJR, MannoEM, etal. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004; 35: 1862-6.
9. WeirB, MacdonaldRL, StoodleyM. Etiology of cerebral vasospasm. Acta Neurochir Suppl (Wien) 1999; 72: 27-46.
10. DumontAS, DumontRJ, ChowMM, LinCL, CalisanellerT, LeyKF, etal. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003; 53: 123-33.
11. PlutaRM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 2005; 105: 23-56.
12. KoliasAG, SenJ, BelliA. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. J Neurosci Res 2009; 87: 1-11.
13. RoosYB, de HaanRJ, BeenenLF, GroenRJ, AlbrechtKW, VermeulenM. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry 2000; 68: 337-41.
14. Dorhout MeesSM, RinkelGJ, FeiginVL, AlgraA, van den BerghWM, VermeulenM, etal. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007: CD000277.
15. HopJW, RinkelGJ, AlgraA, van GijnJ. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997; 28: 660-4.
16. RinkelGJ, FeiginVL, AlgraA, van GijnJ. Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2004: CD000483.
17. IzumiY, RousselS, PinardE, SeylazJ. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1991; 11: 1025-30.
18. MarinovMB, HarbaughKS, HoopesPJ, PikusHJ, HarbaughRE. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg 1996; 85: 117-24.
19. MuirKW. New experimental and clinical data on the efficacy of pharmacological magnesium infusions in cerebral infarcts. Magnes Res 1998; 11: 43-56.
20. van den BerghWM, DijkhuizenRM, RinkelGJ. Potentials of magnesium treatment in subarachnoid haemorrhage. Magnes Res 2004; 17: 301-13.
21. BerthonN, LaurantP, FellmannD, BerthelotA. Effect of magnesium on mRNA expression and production of endothelin-1 in DOCA-salt hypertensive rats. J Cardiovasc Pharmacol 2003; 42: 24-31.
22. KempPA, GardinerSM, MarchJE, RubinPC, BennettT. Assessment of the effects of endothelin-1 and magnesium sulphate on regional blood flows in conscious rats, by the coloured microsphere reference technique. Br J Pharmacol 1999; 126: 621-6.
23. RamZ, SadehM, ShackedI, SaharA, HadaniM. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 1991; 22: 922-7.
24. PyneGJ, Cadoux-HudsonTA, ClarkJF. Magnesium protection against in vitro cerebral vasospasm after subarachnoid haemorrhage. Br J Neurosurg 2001; 15: 409-15.
25. MiuraK. Changes in Mg++ concentration of CSF after subarachnoid hemorrhage and Mg++ - effects on the contractions of bovine cerebral artery. No Shinkei Geka 1988; 16: 1251-9.
26. AlturaBT, AlturaBM. Interactions of Mg and K on cerebral vessels--aspects in view of stroke. Review of present status and new findings. Magnesium 1984; 3: 195-211.
27. SeeligJM, WeiEP, KontosHA, ChoiSC, BeckerDP. Effect of changes in magnesium ion concentration on cat cerebral arterioles. Am J Physiol 1983; 245: H22-H26.
28. TorregrosaG, PeralesAJ, SalomJB, MirandaFJ, BarberaMD, AlborchE. Different effects of Mg2+ on endothelin-1- and 5-hydroxytryptamine-elicited responses in goat cerebrovascular bed. J Cardiovasc Pharmacol 1994; 23: 1004-10.
29. van den BerghWM, AlgraA, van der SprenkelJW, TullekenCA, RinkelGJ. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003; 52: 276-82.
30. van den BerghWM, ZuurJK, KamerlingNA, van AsseldonkJT, RinkelGJ, TullekenCA, etal. Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhage. J Neurosurg 2002; 97: 416-22.
31. van der HelWS, van den BerghWM, NicolayK, TullekenKA, DijkhuizenRM. Suppression of cortical spreading depressions after magnesium treatment in the rat. Neuroreport 1998; 9: 2179-82.
32. WarrenBB, MuizelaarJP, ChoiSC. Magnesium's role in cerebral vasospasm and outcome in patients with aneurysmal subarachnoid hemorrhage. In: FindlayJM, ed. Cerebral Vasospasm. 1993: 401-4.
33. BarbourRL, GebrewoldA, AlturaBT, AlturaBM. Optical spectroscopy and prevention of deleterious cerebral vascular effects of ethanol by magnesium ions. Eur J Pharmacol 2002; 447: 79-86.
34. PearsonPJ, EvoraPR, SeccombeJF, SchaffHV. Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations. Ann Thorac Surg 1998; 65: 967-72.
35. ShechterM. The role of magnesium as antithrombotic therapy. Wien Med Wochenschr 2000; 150: 343-7.
36. van den BerghWM, AlgraA, van KootenF, DirvenCM, van GijnJ, VermeulenM, etal. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005; 36: 1011-5.
37. van NordenAG, van den BerghWM, RinkelGJ. Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage. J Clin Pharm Ther 2005; 30: 439-42.
38. van den BerghWM, AlgraA, RinkelGJ. Magnesium and aspirin treatment in patients with subarachnoid haemorrhage. Comparison of effects after endovascular and neurosurgical aneurysm occlusion. J Neurol 2009; 256: 213-6.
39. WongGK, ChanMT, BoetR, PoonWS, GinT. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study. J Neurosurg Anesthesiol 2006; 18: 142-8.
40. MuroiC, TerzicA, FortunatiM, YonekawaY, KellerE. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surg Neurol 2008; 69: 33-9.
41. VeynaRS, SeyfriedD, BurkeDG, ZimmermanC, MlynarekM, NicholsV, etal. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002; 96: 510-4.
42. Dorhout MeesSM, van den BerghWM, AlgraA, RinkelGJ. Magnesium in Aneurysmal Subarachnoid Hemorrhage (MASH II), a phase III clinical trial. J Int Stroke 2008; 3: 63-5.